Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
10/2010
10/27/2010EP2242498A2 Synergistic antiparasitic compositions and screening methods
10/27/2010EP1386914B1 Halogenated quinoline derivatives and ectoparasite controllers
10/27/2010EP1171124B2 Anthelmintic compositions
10/27/2010CN101869611A Admixture capable of repelling chicken coccidiosis and stopping dysentery and preparation method thereof
10/27/2010CN101297967B Novel use of staphylococcus enterotoxin A gene
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010CA2564684C Use of thioxanthene derivatives as chemosensitising compounds
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2337789C Formulations for controlling human lice
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267702 Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis
10/21/2010US20100267662 Avenanthramide-containing compositions
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100266716 Natural Photodynamic Agents and their use
10/21/2010US20100266640 Plant-Derived Cholera and Malaria Vaccine
10/21/2010US20100266632 Vaccine composition comprising an immunoadjuvant compound consisting of a rho gtpase family activator
10/21/2010US20100266628 Macrocyclic lactone combination compositions, vaccines and methods for producing same
10/21/2010US20100266611 Enhancement of Immune Responses By 4-1BB-Binding Agents
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266510 Foamable Vehicle and Pharmaceutical Compositions Thereof
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241320A1 Aqueous compositions containing metronidazole
10/20/2010EP2241317A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/20/2010CN101868463A Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
10/20/2010CN101863970A Anti-Pf332-DBL region monoclonal antibody capable of restraining invasion of plasmodiumfalciparum
10/20/2010CN101863941A Derivative of 3-oxygen-substituted 6,11-di-oxygen-clarithromycin A
10/20/2010CN101862456A Remedy
10/20/2010CN101862449A Compositions and methods for treatment of candidiasis
10/20/2010CN101862294A Ivermectin suspending agent, preparation method and application thereof
10/20/2010CN101357194B Traditional Chinese medicine for treating Pafeng disease
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816118 Methods for the in vitro culture of Sporozoea sp. and uses thereof
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010CA2443484C Halogen-substituted quinoline derivatives and ectoparasite control agent
10/19/2010CA2366896C Method for the purification, recovery, and sporulation of cysts and oocysts
10/14/2010WO2010116267A1 High dosage doramectin formulation
10/14/2010WO2010116085A1 Cyclic peptides with an anti-parasitic activity
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010US20100261774 Methods for the modulation of Leishmania major infection in mammals
10/14/2010US20100261688 Stabilization of oily suspensions comprising hydrophobic silicas
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260804 Attenuated Uracil Auxotroph of an Apicomplexan and Use Thereof
10/14/2010CA2758103A1 Cyclic peptides with an anti-parasitic activity
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/14/2010CA2750626A1 High dosage doramectin formulation
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2237785A2 Triarylmethane analogs and their use in treating cancers
10/13/2010EP2237774A1 The use of 6-halogeno-ý1,2,4¨-triazolo-ý1,5-a¨-pyrimidine compounds for combating pests in and on animals
10/13/2010EP2237684A2 Agonists for antimicrobial peptide systems
10/13/2010CN101857599A Industrial stereospecific synthesis of beta-artemether by using artemisinin as raw material
10/13/2010CN101559060B Medicine for preventing fish parasitic crustacean diseases, preparation method and application thereof
10/13/2010CN101371850B Use of gracillin in medicament for killing ectoparasite of aquatic animal
10/13/2010CN101205538B Clone, expression and use of Schistosoma Japonicum signal transduction protein Sjwnt-4 gene
10/13/2010CN101190197B Praziquantel chewable tablets for dog or cat
10/13/2010CN101099738B Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7811818 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811569 Recombinant anti-Plasmodium falciparum antibodies
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010112874A1 Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
10/07/2010WO2010112497A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/07/2010US20100256576 Disinfectant Compositions, Methods and Systems
10/07/2010US20100256199 Crystalline form of an Antimalarial Compound
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100255057 Device for actively removing a target cell from blood or lymph of a vertebrate subject
10/07/2010US20100255018 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100254959 Naphthalene isoxazoline invertebrate pest control agents
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/06/2010EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
10/06/2010EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2234973A1 Anthelmintic agents and their use
10/06/2010CN1985813B Metronidazole ethanolamine spray as blood flukedisease preventing and treating medicine for farm cattle and its preparing method
10/06/2010CN101855226A Increasing the in vivo biological activity of biologically active compounds
10/06/2010CN101854928A Avenanthramide-containing compositions
10/06/2010CN101854926A Endoparasiticidal topical compositions
10/06/2010CN101851243A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/06/2010CN101850099A Method for treating ichthyophthiriasis of fish bodies
10/06/2010CN101849937A Medicament compound of ornidazole and dextran and preparation method thereof
10/06/2010CN101336901B Anti-coccidium microemulsion containing toltrazuril and preparation method thereof
10/05/2010US7807660 Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
10/05/2010US7807169 Stratified and cryogenically stored vaccines, process for their preparation
10/05/2010US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria
09/2010
09/30/2010WO2010109172A1 Mannich base tetraoxanes (mannoxanes) and phenol substituted analogues
09/30/2010WO2010062859A3 Recombinantly expressed plasmodium celtos antigen and methods of use thereof
09/30/2010US20100249173 Dihydroquinolinones as ectoparasiticides
09/30/2010US20100249076 Prodrugs of 9-aminomethyl tetracycline compounds
09/30/2010US20100249068 Substituted nucleoside and nucleotide analogs
09/30/2010US20100247576 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof
09/30/2010US20100247554 Use of tam receptor inhibitors as antimicrobials
09/30/2010CA2756757A1 A topical parasiticide composition
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 218